Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
ObvioHealth Welcomes Scott Dixon as Newest Chief Commercial Officer
ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott […]
DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer
DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today […]
Alma Raises $130M in Series D Funding led by Thoma Bravo to Advance its Mission to Simplify Access to High Quality, Affordable Mental Health Care
Alma, a membership-based network that helps independent mental health care providers accept insurance and build […]
Marie- Andrée Gamache Appointed Country President, Novartis Innovative Medicines, UK & Ireland
Novartis UK is announcing that Marie-Andrée Gamache has been appointed to the role of Country […]
Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
Prominent Neurosurgeon Joins Leucadia Therapeutics as Company's Founding Global Chief Medical Officer
Leucadia Therapeutics, a company working to cure Alzheimer’s disease, has hired a global chief medical […]
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head
Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies […]
James Mock Joins Moderna as Chief Financial Officer
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Standigm Names Carl Foster Chief Business Officer to Expand Strategic Partnerships for AI Drug Discovery
Standigm Inc. (“Standigm”), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment […]
Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions
Gune joins Huma to drive further commercial adoption of the company’s digital health platforms in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more